Tag: Generics Medicines Initiative

  • Defining Biosimilars in Oncology: Priyanka Singh Pharma Entrepreneur

    Defining Biosimilars in Oncology: Priyanka Singh Pharma Entrepreneur

    “We are totally committed to improving the safety and wellbeing of all people who work with us, or come into contact with our operations and products”! WHAT IS Biosimilars: Unlike generic chemical medicines where the active ingredients are identical, biosimilars – by definition – are not likely to be identical to the originator biologic. They…

  • Taj Pharma healthcare mission in Russia and CIS countries by 2020

    Taj Pharma healthcare mission in Russia and CIS countries by 2020

    ТАДЖ ФАРМА medicines are dedicated to treat complex health conditions such as renal insufficiency, Cancer, Hepatitis C and HIV infections and other disorders. TAJ PHARMA CIS (ТАДЖ ФАРМА) is Russia’s leading innovative Generics and branded Pharmaceuticals Company; it combines a world-class research and development center, ultra-modern pharmaceutical and generics manufacturing facilities, as well as preclinical…

  • Generics Medicines Initiative Ms. Priyanka Singh Director Taj Pharma

    Generics Medicines Initiative Ms. Priyanka Singh Director Taj Pharma

    Generics Medicines Initiative: The Beginning: We have seen a lot of vertical integration in health care, typically different health care providers merging, or providers and health plans. But integration of providers into pharmaceutical manufacturing setting aside a little compounding — is pretty unprecedented. Well I would say necessity is the mother of invention, right? This…